The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease

L. Roets (Belfast, United Kingdom), D. Doherty (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), A. Krasnodembskaya (Belfast, United Kingdom), M. Mall (Berlin, Germany), C. Taggart (Belfast, United Kingdom), S. Weldon (Belfast, United Kingdom)

Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Session: Cellular responses and cell therapy in lung injury and repair
Session type: Poster Discussion
Number: 3861
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Roets (Belfast, United Kingdom), D. Doherty (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), A. Krasnodembskaya (Belfast, United Kingdom), M. Mall (Berlin, Germany), C. Taggart (Belfast, United Kingdom), S. Weldon (Belfast, United Kingdom). The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease. 3861

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011

Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020

Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017

3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019

iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021



The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018



In search of ckit+ stem cells in lung tissue
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018


Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018

Therapeutic potential of mesenchymal stem cells to attenuate immune cell tolerance in a late stage model of sepsis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016


Therapeutic effects of human perivascular stem cells in an emphysema mouse model
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017

Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009



Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012